HSPH1 and neurodegenerative disease: Several new studies have demonstrated the disaggregative properties of Hsp110 with both model clients such as aggregated luciferase and most significantly with neurodegenerative disease-linked proteins such as α-synuclein and prion protein (Gao et al., 2015; O'Driscoll et al., 2015).